TFS Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-404
| Closed | -$96K | – | 395 |
|
|
2017
Q2 | $96K | Buy |
+404
| New | +$96K | 0.04% | 553 |
|
|
2016
Q1 | – | Sell |
-63
| Closed | -$41K | – | 1120 |
|
|
2015
Q4 | $41K | Sell |
63
-102
| -62% | -$66.4K | ﹤0.01% | 715 |
|
|
2015
Q3 | $78K | Sell |
165
-420
| -72% | -$199K | 0.01% | 821 |
|
|
2015
Q2 | $332K | Buy |
+585
| New | +$332K | 0.03% | 647 |
|
|
2015
Q1 | – | Sell |
-93
| Closed | -$821K | – | 1158 |
|
|
2014
Q4 | $821K | Buy |
93
+40
| +75% | +$353K | 0.08% | 422 |
|
|
2014
Q3 | $248K | Buy |
53
+23
| +77% | +$108K | 0.02% | 813 |
|
|
2014
Q2 | $216K | Buy |
+30
| New | +$216K | 0.02% | 923 |
|